Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company ▾	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ENGN	enGene Therapeutics Inc. Manufacturing · Year ended 2025-10-31 · USD	n/a	-$117.30M	n/a	-69.9%	n/a	$2.29
ATYR	aTYR PHARMA INC Manufacturing · Year ended 2025-12-31 · USD	$190.0K	-$74.12M	n/m	-109.8%	-19.1%	-$0.80
ZURA	Zura Bio Ltd Manufacturing · Year ended 2025-12-31 · USD	n/a	-$68.65M	n/a	-67.6%	n/a	-$1.06
ZEOX	Zeo ScientifiX, Inc. Manufacturing · Year ended 2025-10-31 · USD	$5.20M	-$5.52M	-106.2%	n/a	12.5%	-$0.86
XFOR	X4 Pharmaceuticals, Inc Manufacturing · Year ended 2025-12-31 · USD	$35.11M	-$79.20M	-225.6%	-42.5%	n/m	-$1.87
VYGR	Voyager Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.37M	-$119.72M	-296.5%	-61.1%	-49.5%	-$2.04
VOR	Vor Biopharma Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$695.98M	n/a	n/a	n/a	-$70.50
VIVS	VivoSim Labs, Inc. Manufacturing · Year ended 2026-03-31 · USD	$131.0K	-$13.84M	n/m	n/a	-9.0%	-$5.35
VISK	Viskase Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.41M	n/a	n/a	n/a	-$0.07
VIR	Vir Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$68.56M	-$437.99M	-638.9%	-57.2%	-7.6%	-$3.16
VCEL	Vericel Corp Manufacturing · Year ended 2025-12-31 · USD	$276.26M	$16.52M	6.0%	4.7%	16.5%	$0.32
PCVX	Vaxcyte, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$766.63M	n/a	-28.5%	n/a	-$5.63
VXRT	Vaxart, Inc. Manufacturing · Year ended 2025-12-31 · USD	$237.26M	$16.33M	6.9%	18.6%	726.7%	$0.07
TWST	Twist Bioscience Corp Manufacturing · Year ended 2025-09-30 · USD	$376.57M	-$77.67M	-20.6%	-16.4%	20.3%	-$1.30
TVGN	Tevogen Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.28M	n/a	n/a	n/a	-$8.08
TNYA	Tenaya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$90.60M	n/a	-73.5%	n/a	-$0.59
TECX	Tectonic Therapeutic, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$74.15M	n/a	-29.5%	n/a	-$4.05
TSHA	Taysha Gene Therapies, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.77M	-$109.00M	n/m	-44.1%	17.3%	-$0.34
TARS	Tarsus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$451.36M	-$66.42M	-14.7%	-19.3%	146.7%	-$1.59
TCRX	TScan Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.32M	-$129.77M	n/m	-105.4%	266.7%	-$1.00
SRZN	Surrozen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.48M	-$242.03M	n/m	n/a	-67.4%	-$32.37
SLDB	Solid Biosciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$174.32M	n/a	-96.8%	n/a	-$1.99
SLXN	Silexion Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.91M	n/a	-457.6%	n/a	$8.96
SNTI	Senti Biosciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$22.0K	-$61.44M	n/m	n/m	n/a	-$2.73
SCNI	Scinai Immunotherapeutics Ltd. Manufacturing · Year ended 2025-12-31 · USD	$1.31M	-$8.31M	-633.6%	-102.5%	99.2%	n/a

Rows per page: 2550 100